Aurobindo Pharma Limited has informed the Exchange regarding Notice of Postal Ballot
AUROPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aurobindo Pharma has issued a postal ballot notice seeking shareholder approval to appoint Dr. (Mrs.) Punita Kumar Sinha (DIN: 05229262) as an Independent Director of the company for a 3-year term from February 9, 2026 to February 8, 2029. Dr. Sinha, age 63, is a former Senior Managing Director and CIO at Blackstone Asia Advisors with over 30 years of capital markets experience, a PhD in Finance from the Wharton School, and a Chemical Engineering degree from IIT Delhi; she currently serves on boards of listed firms including Tata Capital, Aadhar Housing Finance, One Mobikwik, and Ventive Hospitality. Shareholders of record as of the cut-off date February 20, 2026 are eligible to vote, with remote e-voting open from February 27, 2026 (9:00 AM IST) to March 28, 2026 (5:00 PM IST). The results will be announced on or before March 30, 2026, and the resolution is being passed as a Special Resolution.
This is a routine governance announcement with no material financial impact, as the appointment adds an independent director with strong finance and capital markets credentials. It is unlikely to move the stock meaningfully but reinforces the board's profile in ESG and governance matters.